{
  "id": 15617993,
  "title": "EyePoint's Phase 3 failure; Lilly's China drug delivery deal",
  "url": "https://urgent.news/2026/10/19/eyepoints-phase-3-failure-lillys-china-drug-delivery-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T15:01:30.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/eyepoints-phase-3-failure-lillys-china-drug-delivery-deal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Longwood's next fund and Ryzumvi's label expansion. EyePoint drug fails, biotech halves staff: The Watertown, MA-based biotech is letting go of 53% of its positions after its experimental ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Vietnam Investment Review",
        "title": "Mabwell presents Phase II trial results for breast cancer drug 9MW2821",
        "url": "https://urgent.news/2026/10/19/mabwell-presents-phase-ii-trial-results-for-breast-cancer-drug-9mw2821",
        "published": "2026-10-19T09:13:43.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Disc Medicine reports 'sun allergy' drug hits Phase 3 home run",
        "url": "https://urgent.news/2026/10/19/disc-medicine-reports-sun-allergy-drug-hits-phase-3-home-run",
        "published": "2026-10-19T11:00:36.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}